Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-13

Clinical Trial Update: Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transdermal testosterone in women with symptomatic heart failure was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal Testosterone (testosterone)

Snippet

Sponsor: Warner Chilcott | Conditions: Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2012-01-13